Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Abstral receives U.K. marketing authorization for breakthrough cancer pain

Sep. 26, 2008

MAA for lacosamide in diabetic neuropathic pain withdrawn; product launched in E.U. for seizures

Sep. 26, 2008

Baxter initiates phase III Gammagard Liquid trial for the treatment of AD

Sep. 26, 2008

Paion presents update on phase I CNS-7056 study

Sep. 26, 2008

Kaken launches new formulation Adofeed Pap 80 mg in Japan

Sep. 26, 2008

Labopharm submits NDA to the FDA for DDS-04A to treat major depression

Sep. 25, 2008

Durect grants worldwide rights to Alpharma for Eladur pain patch

Sep. 25, 2008

FDA requests 3-month extension on PDUFA deadline to review NovaDel's Zolpimist

Sep. 25, 2008

Transdel enrolls first patient in Ketotransdel phase III registration study

Sep. 25, 2008

KeyNeurotek receives EMEA orphan drug designation for KN-38-7271

Sep. 23, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...